Cargando…
Gestational diabetes mellitus—right person, right treatment, right time?
BACKGROUND: Personalised treatment that is uniquely tailored to an individual’s phenotype has become a key goal of clinical and pharmaceutical development across many, particularly chronic, diseases. For type 2 diabetes, the importance of the underlying clinical heterogeneity of the condition is emp...
Autores principales: | Lindsay, Robert S., Mackin, Sharon T., Nelson, Scott M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572161/ https://www.ncbi.nlm.nih.gov/pubmed/28844206 http://dx.doi.org/10.1186/s12916-017-0925-2 |
Ejemplares similares
-
The time is right for an Antarctic biorepository network
por: O’Brien, Kristin M., et al.
Publicado: (2022) -
Post COVID-19 Organizing Pneumonia: The Right Time to Interfere
por: Bieksiene, Kristina, et al.
Publicado: (2021) -
Targeting the right interventions to the right people and places: the role of geospatial analysis in HIV program planning
por: Meyer-Rath, Gesine, et al.
Publicado: (2018) -
The Rights of Children on the Move and the Budapest Declaration
por: Oberg, Charles
Publicado: (2018) -
COVID-19 pandemic: Is it the right time to develop interconnected national biomedical registries?
por: Kotoulas, Athanasios S.
Publicado: (2021)